Skip to content

Effect of Ginger (Zinger offiicinale Roscoe) on patients with slow coronary flow

Effect of Ginger (Zinger offiicinale Roscoe) on clinical symptoms in patients with slow coronary flow on angiography

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230625058582N1
Enrollment
48
Registered
2023-07-29
Start date
2023-07-23
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary slow flow syndrome. Other forms of angina pectoris

Interventions

Intervention 1: Intervention group: Patients with slow coronary artery disease receiving routine treatment (including aspirin, statins, beta-blockers and angiotensin-converting enzyme inhibitors) alon

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent to admission to the study Age more than 30 years old Patients who have less than 50% stenosis in each of the 3 main coronary arteries in their coronary angiography and have delayed filling in at least one of the coronary arteries and have slow coronary flow in a corrected TIMI frame count of more than 27 frames per second

Exclusion criteria

Exclusion criteria: Stomach ulcers or duodenal ulcers Taking anticoagulants such as warfarin, aspirin and enoxaparin Breastfeeding or pregnancy Consumption of omega 3 (fish oil), ciprofloxacin, loratadine, citalopram, montelukast, and levothyroxine Kidney stone History of known congenital heart disease History of any cardiovascular diseases other than mild coronary atherosclerosis

Design outcomes

Primary

MeasureTime frame
Changes in the score of quality of life according to the EuroQol-VAS scale (0-100; 100 is the best quality of life and 0 is the worst quality of life). Timepoint: Before intervention and one month after beginning the intervention. Method of measurement: According to the EuroQol-VAS scale (0-100; 100 is the best quality of life and 0 is the worst quality of life).

Secondary

MeasureTime frame
Frequent pain during the day. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Checklist.;Duration of pain in minutes. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Checklist.;Quality of life according to Seattle Angina Questionare. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Seattle Angina Questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sara Afshar

Mashhad University of Medical Sciences

afshars@mum.ac.ir+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026